Cell Therapy Bioprocessing Market is expected to reach US$ 30,052.61 million by 2028

by Sameer Joshi or 30-Apr-2021
     Request For Sample

Report : Cell Therapy Bioprocessing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Bioreactor, Lyophilization, Electrospinning, Controlflow Centrifugation, Ultrasonic Lysis, Genome Editing Technology, Cell Immortalization Technology, And Viral Vector Technology), Cell Type (Stem Cell, Immune Cell, Human Embryonic Stem Cell, Pluripotent Stem Cell, and Hematopoetic Stem Cells), Indication (Cardiovascular Disease (CVD), Oncology, Wound Healing, Orthopedic, and Others), End User (Hospitals and Clinics, Diagnostic Centers, Regenerative Medicine Centers, and Academic and Researc

Bioreactor Segment to Gain Traction in Cell Therapy Bioprocessing Market During 2021–2028

According to our new research study on “Cell Therapy Bioprocessing Market Forecast to 2028 – COVID-19 Impact and Analysis – by technology, cell type, end user,” the market is expected to reach US$ 30,052.61 million in 2028 from US$ 11,192.50 million in 2020. The market is estimated to grow with a CAGR of 13.5% from 2021-2028. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.
 
A bioreactor is a cell culture vessel that is self-contained and equipped with sensors. It’s commonly cylindrical in shape, ranging in size from liters or cubic meters, and are often made of stainless steel. Bioreactors have been used in a variety of processes for decades, from alcohol fermentation to organic waste biodegradation to antibody and vaccine production. Though they are still used for these purposes today, bioreactors are an important enabling technology that is increasingly being adopted for the production of cell and gene therapies. Bioreactors mainly STRs (stirred tank reactors) have been widely adopted by the bioprocess sector to culture bacteria or yeast. The ability to monitor and regulate key parameters such as temperature, pH, and dissolved oxygen defines bioreactors from traditional R&D cell culture. Continuous, in situ monitoring of these parameters allows for a deep understanding of a cell population's growth environment, creating opportunities for process improvement. Bioreactors can help with the development of processes by providing built-in controls that meet these needs.  Firstly, bioreactors have a closed and aseptic atmosphere as standalone culture vessels. To avoid the risks associated with sterilizing reusable vessels, the industry is increasingly moving to single-use, disposable bioreactors.
 
Fresenius Kabi AG, Asahi Kasei Corporation, Sartorius AG, Merck KGaA, Thermo Fisher Scientific Inc, Corning Incorporated, Cytiva (GE Healthcare), Lonza, Repligen, and Catalent Inc; are among the leading companies in the cell therapy bioprocessing market. 
 
The report segments global cell therapy bioprocessing market as follows:
 
By Technology
  • Bioreactor
  • Lyophilization
  • Electrospinning
  • Controlflow Centrifugation
  • Ultrasonic Lysis
  • Genome Editing Technology
  • Cell Immortalization Technology
  • Viral Vector Technology
By Cell Type
  • Stem Cell
  • Immune Cell
  • Human Embryonic Stem Cell
  • Pluripotent Stem Cell
  • Hematopoetic Stem Cell
By Indication
  • Cardiovascular Disease (CVD)
  • Oncology
  • Wound Healing
  • Orthopedic
  • Others
By End User
  • Hospitals and Clinics
  • Diagnostic Centers
  • Regenerative Medicine Centers
  • Academic and Research Institute
By Geography
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of APAC
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM
Contact Us
Contact Person: Sameer Joshi 

Phone: +1-646-491-9876
Email Id: sales@reportsweb.com